These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

688 related items for PubMed ID: 8959085

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II.
    Seissler J, Schott M, Steinbrenner H, Peterson P, Scherbaum WA.
    Exp Clin Endocrinol Diabetes; 1999; 107(3):208-13. PubMed ID: 10376448
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease.
    Uibo R, Aavik E, Peterson P, Perheentupa J, Aranko S, Pelkonen R, Krohn KJ.
    J Clin Endocrinol Metab; 1994 Feb; 78(2):323-8. PubMed ID: 8106620
    [Abstract] [Full Text] [Related]

  • 6. Autoantibodies in autoimmune polyendocrine syndrome type II.
    Falorni A, Laureti S, Santeusanio F.
    Endocrinol Metab Clin North Am; 2002 Jun; 31(2):369-89, vii. PubMed ID: 12092456
    [Abstract] [Full Text] [Related]

  • 7. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease.
    Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kämpe O.
    J Clin Invest; 1993 Nov; 92(5):2377-85. PubMed ID: 8227354
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side-chain cleavage and 17alpha-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III.
    de Carmo Silva R, Kater CE, Dib SA, Laureti S, Forini F, Cosentino A, Falorni A.
    Eur J Endocrinol; 2000 Feb; 142(2):187-94. PubMed ID: 10664529
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Autoimmunity in isolated Addison's disease and in polyglandular autoimmune diseases type 1, 2 and 4.
    Betterle C, Dalpra C, Greggio N, Volpato M, Zanchetta R.
    Ann Endocrinol (Paris); 2001 Apr; 62(2):193-201. PubMed ID: 11353894
    [Abstract] [Full Text] [Related]

  • 13. Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features.
    Myhre AG, Undlien DE, Løvås K, Uhlving S, Nedrebø BG, Fougner KJ, Trovik T, Sørheim JI, Husebye ES.
    J Clin Endocrinol Metab; 2002 Feb; 87(2):618-23. PubMed ID: 11836294
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Autoantibodies against aromatic L-amino acid decarboxylase identifies a subgroup of patients with Addison's disease.
    Söderbergh A, Rorsman F, Halonen M, Ekwall O, Björses P, Kämpe O, Husebye ES.
    J Clin Endocrinol Metab; 2000 Jan; 85(1):460-3. PubMed ID: 10634424
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.